- Research works
- 92 ▲ 53% vs 2013–17
- Citations
- 1.7k 18.9 per fractional work
- Top-10% rate
- 8.9% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: Japan BCG Laboratory is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.2×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 10.2×
- Immunology and Microbiology 10.0×
- Neuroscience 3.7×
- Chemical Engineering 3.4×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Energy 1.9×
- Medicine 1.5×
- Materials Science 1.4×
- Computer Science 1.3×
- Chemistry 1.1×
- Psychology 1.0×
- Engineering 0.6×
- Agricultural and Biological Sciences 0.4×
- Health Professions 0.2×
Who are the top researchers at Japan BCG Laboratory?
Ranked on the composite score, Ichiro Toida lead among researchers whose main affiliation is Japan BCG Laboratory.
- 1 Ichiro Toida Japan · #1,310,879 worldwide 2 citations · 19 works
Which keywords describe research at Japan BCG Laboratory?
By fractional works in all years, weighted toward what it does more of than the world: Treatment, Diagnosis, Epidemiology, Immune Response, Vaccine, Genetic Diversity, Drug Resistance and Mycobacterium tuberculosis.
- Oligosaccharide Synthesis
- Urothelial Carcinoma
- Bladder Cancer
- NK Cell Recognition
- Cytokine-Mediated Link
- Tumor Antigen
- Dendritic Cells
- Antigen Presentation
- Antiretroviral Therapy
- Immunity
- Trained Immunity
- Innate Memory
- Immune Dysregulation
- Inflammation
- Nontuberculous Mycobacteria
- Antibiotic Resistance
- Mycobacterium tuberculosis
- Genetic Diversity
- Immune Response
- Treatment
- Epidemiology
- Diagnosis
- Vaccine
- Drug Resistance
- Tuberculosis
- Mycobacterium avium
- Genetic Mutations
- Epigenetic Reprogramming
- Human Inborn Errors
- Primary Immunodeficiency
- Immunotherapy
- Innate Immunity
- Guidelines
- Cancer Immunotherapy
- Pattern Recognition Receptors
- Toll-like Receptors
- Innate Antiviral Responses
- Natural Killer Cells
- Gene Therapy
- Glycosidase Inhibitors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology21▲ 5.6×29 topics
- Treatment18▲ 15×10 topics
- Diagnosis18▲ 19×10 topics
- Immune Response10▲ 18×8 topics
- Vaccine10▲ 27×6 topics
- Genetic Diversity9▲ 19×2 topics
- Drug Resistance9▲ 30×2 topics
- Mycobacterium tuberculosis9▲ 143×1 topic
- Tuberculosis9▲ 173×1 topic
- Antibiotic Resistance8▲ 21×5 topics
- Mycobacterium avium7▲ 167×1 topic
- Nontuberculous Mycobacteria7▲ 167×1 topic
- Genetic Mutations5▲ 10×5 topics
- Inflammation5▲ 2.1×17 topics
- Epigenetic Reprogramming4▲ 60×2 topics
- Immune Dysregulation4▲ 57×2 topics
- Human Inborn Errors4▲ 112×1 topic
- Innate Memory4▲ 342×1 topic
- Primary Immunodeficiency4▲ 112×1 topic
- Trained Immunity4▲ 342×1 topic
- Immunotherapy4▲ 6.0×8 topics
- Immunity3▲ 10×5 topics
- Innate Immunity3▲ 8.8×4 topics
- Antiretroviral Therapy2▲ 11×5 topics
- Guidelines2▲ 5.5×3 topics
- Antigen Presentation2▲ 25×2 topics
- Cancer Immunotherapy2▲ 18×2 topics
- Dendritic Cells2▲ 20×1 topic
- Pattern Recognition Receptors2▲ 16×2 topics
- Tumor Antigen2▲ 29×1 topic
- Toll-like Receptors2▲ 14×2 topics
- Cytokine-Mediated Link2▲ 31×1 topic
- Innate Antiviral Responses2▲ 31×1 topic
- NK Cell Recognition2▲ 22×1 topic
- Natural Killer Cells2▲ 22×1 topic
- Bladder Cancer2▲ 55×1 topic
- Gene Therapy2▲ 7.6×3 topics
- Urothelial Carcinoma2▲ 47×1 topic
- Glycosidase Inhibitors2▲ 38×1 topic
- Oligosaccharide Synthesis2▲ 38×1 topic
Which research topics does Japan BCG Laboratory publish most on?
By volume in 2022–2025: Immune responses and vaccinations, SARS-CoV-2 and COVID-19 Research, Tuberculosis Research and Epidemiology and Protein purification and stability.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune responses and vaccinations Immunology 0 works
- 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 3 Tuberculosis Research and Epidemiology Infectious Diseases 0 works
- 4 Protein purification and stability Molecular Biology 0 works
- 5 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
- 6 Enzyme Production and Characterization Biotechnology 0 works
- 7 EEG and Brain-Computer Interfaces Cognitive Neuroscience 0 works
- 8 Organic Light-Emitting Diodes Research Electrical and Electronic Engineering 0 works
- 9 Immunotherapy and Immune Responses Immunology 0 works
- 10 Bacterial Genetics and Biotechnology Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Japan BCG Laboratory's research output changed?
Output in 2018–2022 was 53% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.